In 2012, University of Alabama at Birmingham researcher Anath Shalev, M.D., reported that a decades-old blood pressure medication called verapamil completely reversed diabetes in animal models.
These results add an additional, mechanistic aspect to further explain how the decades-old blood pressure medication verapamil can preserve beta cell function in Type 1 diabetes patients by affecting the hormone insulin-.
TIXiMED Chief Scientific Officer Presents at 2023 Immunology of Diabetes Society Congress tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Dr. Anath Shalev, renowned diabetes researcher and Chief Scientific Officer of TIXiMED, Inc., a company dedicated to the development and commercialization of TXNIP inhibiting medications, presented her work on verapamil and TXNIP inhibition at the 2023 Immunology of Diabetes Society Congress in Paris.BIRMINGHAM, Ala.
An oral medication reveals benefits treating Type 1 diabetes for at least two years after diagnosis miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.